Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global marketplace, the drug approval standard employed by FDA remains a perennial focus of stakeholders across the industry.
The Government Accountability Office has agreed to investigate recent CFPB moves to fire more than 1,400 employees and the impact it and other agency actions have had on the bureau’s ability to operate.... By: Ballard Spahr LLP
A rising number of plan participants are making early 401(k) hardship withdrawals. A report by Vanguard found that 4.8% of participants initiated a hardship withdrawal in 2024, which us up from 3.6% in 2023....
On April 23, 2025, the Canadian Securities Administrators (CSA) announced that it is pausing its efforts to develop new and enhanced climate and diversity-related disclosure rules for public companies in Canada.
Since the start of 2025, the following states have added to the roadwork on artificial intelligence regulation in insurance by implementing the NAIC’s model bulletin on the use of AI systems by insurers...... By: Carlton Fields
Given the hubbub over the SEC’s new EDGAR Next, I thought it would be useful to provide a FAQ explaining the rationale for Section 16 to a new director or officer who is unfamiliar with the concept.... By: Cooley LLP
On April 23, 2025, President Donald Trump signed an executive order called “Reforming Accreditation to Strengthen Higher Education” along with a fact sheet about the EO and six other EOs relating to education....
Kilpatrick’s Jordan Goodman recently participated in a panel titled – “Is There any Limit to What Constitutes Tangible Personal Property?" - at the Council on State Taxation (COST) Spring Meeting in New Orleans.
